Application Nr Approved Date Route Status External Links
NDA208114 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Defitelio Is Indicated For The Treatment Of Adult And Pediatric Patients With Hepatic Veno-Occlusive Disease (Vod), Also Known As Sinusoidal Obstruction Syndrome (Sos), With Renal Or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation (Hsct). Defitelio Is Indicated For The Treatment Of Adult And Pediatric Patients With Hepatic Veno-Occlusive Disease (Vod), Also Known As Sinusoidal Obstruction Syndrome (Sos), With Renal Or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation (Hsct). ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Defibrotide Sodium

Comments